Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
symbols : Bmy save search
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | News | $129.21 |
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | News | $85.28 0.53% 0.02% |
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
LLY | News S | $327.27 0.51% 0.04% |
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $43.7 0.02% 0.05% |
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
GLAXF | News | $21.1 |
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
PFE | News | $51.88 0.56% 0.04% |
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
SPPI | News A | $0.8667 -1.51% 0.0% |
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNYNF | News | $104.5 |
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.78%
H: 1.72%
C: 0.95%
SNY | News | $52.62 -1.5% -0.41% |
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | News | $66.465 -0.65% -0.42% |
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.78%
H: 1.72%
C: 0.95%
BAX | News | $66.71 -0.11% 0.0% |
|
Health Technology
|
| O: 4.39%
H: 0.97%
C: -0.09%
BMRN | News | $85.03 -2.1% -0.4% |
|
Health Technology
|
| O: 1.23%
H: 0.57%
C: -1.48%
NVO | News | $112.89 0.69% 0.0% |
|
Health Technology
|
| O: 0.78%
H: 0.97%
C: 0.19%
KMDA | News | $4.61 0.0% |
|
Health Technology
|
| O: -1.52%
H: 0.67%
C: -0.88%
ABEO | News | $0.1824 7.29% 6.47% |
|
Health Technology
|
| O: -5.43%
H: 9.2%
C: 5.23%
care for therapeutics growth
Bristol Myers Squibb Presents New Data Showing Effect of Early Zeposia (ozanimod) Treatment in Improving and Preserving Cognitive Function in People With Relapsing Multiple Sclerosis
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: 0.0%
treatment sclerosis
New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia (ozanimod)
Published: 2022-06-24 (Crawled : 20:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: 0.0%
covid-19 response sclerosis
SHAREHOLDER ALERT: Weiss Law Reminds MBII, VMW, TPTX, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-24 (Crawled : 19:00) - prnewswire.com
AVGO | $505.89 -0.63% 0.18% |
|
Electronic Technology
| Email alert
Add to watchlist
HMTV | $7.925 16.2% 0.0% |
|
Consumer Services
| Email alert
Add to watchlist
VMW | $117.66 -0.25% 0.68% |
|
Technology Services
| Email alert
Add to watchlist
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
| Email alert
Add to watchlist
MBII | News | $1.02 4.4% 3.38% |
|
Process Industries
| Email alert
Add to watchlist
TPTX | $75.27 0.13% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
ongoing
European Medicines Agency Validates Bristol Myers Squibb’s Application for CAR T Cell Therapy Breyanzi in Relapsed or Refractory Large B-cell Lymphoma After First-Line Therapy
Published: 2022-06-20 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
| Email alert
Add to watchlist
for application therapy
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-17 (Crawled : 19:00) - prnewswire.com
CNXC | News | $147.67 1.63% -0.04% |
|
Information
| Email alert
Add to watchlist
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
| Email alert
Add to watchlist
TPTX | $75.27 0.13% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
BRKL | $13.44 0.9% 0.0% |
|
Finance
| Email alert
Add to watchlist
SREV | News | $1.45 -2.76% |
|
Technology Services
| Email alert
Add to watchlist
PCSB A | $19.17 0.31% 0.0% |
|
Finance
| Email alert
Add to watchlist
HMTV | $7.925 16.2% 0.0% |
|
Consumer Services
| Email alert
Add to watchlist
CNXCV | News | $2.27 0% |
|
Commercial Services
| Email alert
Add to watchlist
ongoing
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
SNY | News | $52.62 -1.5% -0.41% |
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
AZN | News | $66.465 -0.65% -0.42% |
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
SNYNF | News | $104.5 |
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GLAXF | News | $21.1 |
|
Health Technology
|
| O: 0.01%
H: 0.17%
C: 0.17%
NVSEF | News | $84.01 |
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
GSK | News | $43.7 0.02% 0.05% |
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AZNCF | News | $129.21 |
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -0.64%
NVS | News | $85.28 0.53% 0.02% |
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
active report roche sanofi market diagnostic
Immunomodulators Market: Trends & Opportunities | Global Industry Analysis [2021-2031] The demand in the global immunomodulators market is expected to increment at a potent CAGR during the forecast period of 2017 to 2025, which can be attributed to a number of key factors, such as increasing adoption of monoclonal antibodies, presence of strong pipeline portfolio, strong adoption of TNF-alpha inhibitors and B-cell inhibitors, advancements in the diagnostic tools, and the development of novel therapies using innovative technologies. In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market | Forecast [2021-2031] In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. Isothermal Nucleic Acid Amplification Technology Market Analysis and Opportunity Assessment up to 2031 Wilmington, Delaware, United States: Surge in the prevalence of different infectious diseases globally is projected to create substantial opportunities for sales growth in the isothermal nucleic acid amplification technology market during the forecast period of 2021 to 2031. Medical Sensors Market to Gain US$ 32.15 Bn by 2028, Growing Awareness about Health and Fitness to Drive Global Market Wilmington, Delaware, United States: According to the report, the global medical sensors market was valued at US$ 15.23 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028. Oral Care Products Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031. Pharmacovigilance Market: Size | Share | Trends | Global Industry Outlook, 2031 Pharmacovigilance is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. Stoma Care Market Insights by Size, Status and Forecast 2031 Wilmington, Delaware, United States: Because of the high frequency of bladder cancer and colorectal cancer, growing number of activities to develop awareness about stoma, rising demand for stoma care and accessories, and technological developments is expected to drive global stoma care market in the near future. Structural Biology and Molecular Modeling Techniques Market | Global Industry Analysis [2021-2031] The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases. Addiction Treatment Market to Generate US$ 12 Bn by 2030 | Growth & Key Business Strategies Wilmington, Delaware, United States: According to the report, the global addiction treatment market was valued at ~US$ 6 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Antibacterial Drugs Market: Increasing Prevalence of Infectious Diseases to Drive the Market Wilmington, Delaware, United States: Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria. Antifungal Drugs Market Demand and Global Competitive Insights 2031 Wilmington, Delaware, United States: The growing threat of fungal infections among a considerable chunk of the global populace is estimated to bring considerable growth prospects for the antifungal drugs market during the forecast period of 2021-2031. Bioimpendance Analysers Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The demand in the global bioimpendance analysers market is surging owing to high growth potential amongst emerging economies such as Brazil and India. Bioinformatics Services Market Worldwide Major Trend Outlook 2021 to 2031 Wilmington, Delaware, United States: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others. Biomedical Refrigerators and Freezers Market: Trends, Regional Outlook and Competitive Analysis [2021-2031]
Published: 2022-06-17 (Crawled : 08:00) - biospace.com/
NVS | News | $85.28 0.53% 0.02% |
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
LLY | News S | $327.27 0.51% 0.04% |
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
NVSEF | News | $84.01 |
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
JNJ | News | $182.12 -0.09% 0.1% |
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: 0.0%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
sales treatment care trends brazil services for antibacterial growing diagnostic health expected infections technology diagnostics potential molecular cancer growth negative market
Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors
Published: 2022-06-15 (Crawled : 22:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.4%
H: 0.6%
C: -0.19%
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published: 2022-06-14 (Crawled : 11:00) - prnewswire.com
ABBV | News | $153.14 0.53% 0.04% |
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
JNJ | News | $182.12 -0.09% 0.1% |
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: -0.4%
H: 0.33%
C: -0.91%
UCBJY | $42.91 |
|
Manufacturing
|
| O: -0.22%
H: 0.0%
C: -1.02%
PFE | News | $51.88 0.56% 0.04% |
|
Health Technology
|
| O: -2.24%
H: 0.0%
C: 0.0%
AMGN | News | $244.89 -0.2% -0.56% |
|
Health Technology
|
| O: -0.41%
H: 0.73%
C: -0.54%
TAK | News | $14.06 1.59% 0.0% |
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
LLY | News S | $327.27 0.51% 0.04% |
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
research system companies market
SHAREHOLDER ALERT: Weiss Law Reminds TPTX, PCSB, SREV, and HMTV Shareholders About Its Ongoing Investigations
Published: 2022-06-10 (Crawled : 19:00) - prnewswire.com
SREV | News | $1.45 -2.76% |
|
Technology Services
| Email alert
Add to watchlist
CNXCV | News | $2.27 0% |
|
Commercial Services
| Email alert
Add to watchlist
BRKL | $13.44 0.9% 0.0% |
|
Finance
| Email alert
Add to watchlist
PCSB A | $19.17 0.31% 0.0% |
|
Finance
| Email alert
Add to watchlist
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
| Email alert
Add to watchlist
HMTV | $7.925 16.2% 0.0% |
|
Consumer Services
| Email alert
Add to watchlist
TPTX | $75.27 0.13% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
CNXC | News | $147.67 1.63% -0.04% |
|
Information
| Email alert
Add to watchlist
ongoing
Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022
Published: 2022-06-08 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.41%
H: 0.39%
C: -0.44%
report for results
Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Published: 2022-06-07 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
conference
Ayala Pharmaceuticals Announces Data on AL101 in Adenoid Cystic Carcinoma (ACC) at 2022 ASCO Annual Meeting
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
AYLA | $1.13 5.61% 18.22% |
|
Health Technology
|
| O: 0.0%
H: 3.42%
C: 2.33%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
al101 asco
Three-Year Data from Phase 3 CheckMate -9LA Trial Demonstrate Long-Term, Durable Survival Outcomes of Opdivo (nivolumab) Plus Yervoy (ipilimumab)
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
opdivo trial plus
Landmark Five-Year Data from Phase 3 CheckMate -227 Trial Demonstrate Long-Term, Durable Survival Outcomes with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
treatment opdivo trial plus cancer
SHAREHOLDER ALERT: Weiss Law Investigates Turning Point Therapeutics, Inc.
Published: 2022-06-03 (Crawled : 19:00) - prnewswire.com
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
| Email alert
Add to watchlist
TPTX | $75.27 0.13% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
Published: 2022-06-03 (Crawled : 12:00) - biospace.com/
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
TPTX | $75.27 0.13% 0.0% |
|
Health Technology
|
| O: 120.04%
H: 0.0%
C: 0.0%
Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
BIIB | $213.56 0.77% 0.0% |
|
Health Technology
|
| O: 1.16%
H: 3.3%
C: 1.27%
GLPG | $55.94 0.32% 2.13% |
|
Health Technology
|
| O: 0.29%
H: 2.68%
C: 2.39%
AZNCF | News | $129.21 |
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
FGEN F | $11.66 0.34% 0.0% |
|
Health Technology
|
| O: 1.57%
H: 2.99%
C: 2.99%
AZN | News | $66.465 -0.65% -0.42% |
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
BMY | News | $79.98 1.29% 0.34% |
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
fibrosis research growing market
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ABBV | News | $153.14 0.53% 0.04% |
|
Health Technology
APPN | News 4 | $54.46 -1.05% 0.38% |
|
Technology Services
APPS | News | $17.62 1.62% 5.48% |
|
Technology Services
APYX | News | $6.04 1.51% 0.0% |
|
Health Technology
BNPQF | News | $50.78 |
|
Finance
BNPQY | News | $25.46 |
|
Finance and Insurance
BNPZY | News | $ 0% |
|
Finance and Insurance
CNXC | News | $147.67 1.63% -0.04% |
|
Information
CNXCV | News | $2.27 0% |
|
Commercial Services
DMYD | News | $16.21 0% |
|
Finance
DMYT | News | $22.76 0% |
|
Finance
DRE | News | $56.17 -2.23% 0.0% |
|
Finance
EPZM | News | $1.47 54.09% 7.97% |
|
Health Technology
ET | News | $10.14 0.4% 0.59% |
|
Industrial Services
FBNC | News | $35.7 2.32% 0.0% |
|
Finance
FBP | News | $13.52 0.67% 0.0% |
|
Finance
FTRP | News | $0.81 1.25% 0.0% |
|
Health Care and Social Assistan...
GRRB | News | $30.6 |
|
Finance and Insurance
HR | News | $27.23 1.38% 0.0% |
|
Finance
HTA | News | $27.7 -0.22% 0.0% |
|
Finance
IE | News 0 d new | $ 0% |
|
n/a
IONQ | News | $4.83 -5.48% 2.07% |
|
Professional, Scientific, and T...
LLY | News 4 | $327.27 0.51% 0.04% |
|
Health Technology
LMPX | News | $4.62 0.43% 0.0% |
|
Technology Services
NFLX | News | $189.14 -0.9% 0.52% |
|
Consumer Services
OBCI | News | $12.86 0.0% |
|
Consumer Non-Durables
OMC | News | $64.75 0.23% 0.0% |
|
Commercial Services
ONEW | News | $35.25 3.68% 0.0% |
|
Retail Trade
OSCR | News | $4.55 2.94% 0.0% |
|
PACB | News | $5.3 -5.53% -1.78% |
|
Health Technology
PEGA | News | $51.68 -1.97% 0.0% |
|
Technology Services
PFHC | News | $19.75 6.35% -4.95% |
|
PLD | News | $120.21 -1.94% 0.54% |
|
Finance
PSORF | News | $9.55 0% |
|
Consumer Services
RDUS | News | $10.205 0.94% -0.4% |
|
Health Technology
SNY | News | $52.62 -1.5% -0.41% |
|
Health Technology
SNYNF | News | $104.5 |
|
Health Technology
SPRO | News | $0.931 -0.96% 3.19% |
|
Health Technology
SREV | News | $1.45 -2.76% |
|
Technology Services
TGTX | News | $4.34 -1.36% -2.05% |
|
Health Technology
TUP | News 4 | $7.16 1.42% 0.0% |
|
Producer Manufacturing
USAK | News | $30.85 -0.48% -0.39% |
|
Transportation
USWS | News | $0.995 4.08% -0.63% |
|
Finance
VRCA | News | $2.195 4.03% 10.43% |
|
Health Technology
WWE | News | $61.0 0.63% 0.0% |
|
Consumer Services
XRAY | News | $36.74 -0.05% 0.0% |
|
Health Technology
ZEN | News | $74.65 0.65% -0.07% |
|
Technology Services